Methods
The Texas Department of State Health Services collects information on the Hantavirus pulmonary syndrome using the Centers for Disease Control and Prevention, Special Pathogens Branch case report form (OMB No.0920-0090). This form collects patient demographics, patient exposure information, timeline, clinical information, laboratory tests, viral studies, and outcomes. We retrospectively reviewed data for 45 cases obtained from the Texas Department of State Health Services, consisting of 44 case report forms, and a spreadsheet summarizing data for one patient for whom the form was missing. All personal identifying information was redacted from these forms. In addition, not all reports included a complete summary of information relevant to the particular patient. However, the State Department of Health Services indicated that these were confirmed cases based on information on the form and other information which was not available to these investigators. 
results
This study included 45 patients with Hantavirus pulmonary syndrome identified in Texas between 1993 and 2016. The median age was 32 years (25-50 interquartile range); 31 patients were male (68.9%). The ethnic distribution included 23 white non-Hispanic patients, 18 Hispanic patients, one black patient, and three patients with no information. Thirty-two cases reported rodent exposure in the environment, five denied exposure, six had unknown exposure, and one reported possible exposure. Detailed records were missing from one case. Thirty-one cases reported the deer mouse (Peromyscus maniculatus) as the source of exposure and three cases, involving the Bayou virus in southeastern Texas, were associated with marsh rice rats (Oryzomis palustris). Thirty-four cases were associated with the Sin Nombre species (SNV), five were associated with Bayou or Bayoulike species, and six had inadequate information for Texas since 1993. Most patients were young white men in Northwest Texas and had leukocytosis (75% of patients), an increased percent bands (91%), elevated hematocrits (68%), reduced platelet counts (92%), elevated creatinine (53%), fever, and abnormal chest x-rays consistent with interstitial/alveolar edema. They often required mechanical ventilation, and the case fatality exceeded 31%. The case fatality rate for SNV was 38%; the rate for the Bayou/ Bayou-like viruses was 20%. In the initial report from the United States the mean age was 32 years, 61% were women, and 72% were Native Americans. 3 The case fatality rate in the current series is slightly lower; this may reflect better supportive care or more reports of "mild" cases. The majority of cases continue to occur in the Texas Panhandle and in Southeast Texas.
These infections develop after exposure to rodents, especially deer mice, and rodent excretions. 5 However, important details about the pathogenesis of these infections remain incomplete, and treatment information is quite limited. Brocato and coworkers have developed a hamster model of Hantavirus pulmonary syndrome using immunosuppression with dexamethasone and cyclophosphamide. 6 Immunosuppressed animals developed clinical signs of Hantavirus pulmonary syndrome, had pulmonary edema on histology, and had viral antigen present throughout the pulmonary endothelium. Hantavirus specific neutralizing polyclonal antibody administered five days after infection provided significant protection against this disease. Safronetz et al have developed a model for Hantavirus infection in rhesus macaques. 7 These animals rapidly develop respiratory distress and have an immune response preferentially localized to the pulmonary interstitium despite having widespread endothelial infection. These models provide the opportunity to study antiviral drugs and antisera in controlled studies. 8, 9 This information is essential to provide specific therapy for this sporadic disease.
We also need more complete information on the seasonal distribution of these infections, the relationship with rodent population density, rodent susceptibility to infection, and viral titers in rodents. Rodent population densities vary across geographic regions and across seasons. 10 The Centers for Disease Control and Prevention recently reported that 17 patients in seven states have been infected with the Seoul virus following exposure to infected rats shipped from two facilities in Illinois and Wisconsin (Multi-state outbreak of Seoul virus. www.cdc. gov/hantavirus/outbreaks/seoul-virus/index.html, accessed 4-28-2017). The Seoul virus causes a different clinical syndrome (hemorrhagic fever with renal syndrome); there have been no reports of Hantavirus pulmonary syndrome acquired through the shipment of pet rodents. However, the potential for widespread distribution of infected rodents throughout the United States greatly complicates epidemiologic studies of Hantavirus pulmonary syndrome, if this were to occur.
In summary, Hantavirus pulmonary syndrome continues to occur at a low and sporadic rate in Texas. There are no consistent factors known to predispose humans to severe disease; it is unknown whether severe presentations represent overwhelming viral infections, increased viral virulence, defective host defense responses, or exuberant pro-inflammatory host defense responses causing multiorgan failure. There is no definitive treatment other than supportive care; our results suggest that outcomes have improved over the last 10 years. Animal models provide the potential to identify specific treatment based on immunoglobulin administration or viral drugs. Most clinicians will never encounter a patient with this syndrome. Since it occurs more frequently in certain regions, this information provides the basis for health professional and public health education with a focus on prevention.
